HUBBARD, Ohio--(BUSINESS WIRE)--NanoLogix Inc. (OTCBB: NNLX), an innovator in the rapid detection, identification of live bacteria, and determination of their antibiotic resistance and sensitivity, announces that a New World Standard for Petri plate shelf life and storage conditions has been established by NanoLogix. The Company has been informed that ongoing tests by the world’s largest private Research and Development corporation have shown NanoLogix Tryptic Soy Agar (TSA) plates packed in exclusive, patented FlatPack® packaging for 19 months performing as well as one-week old competitor’s plates. With this milestone, NanoLogix petri plate shelf life has reached nearly 10 times the competition’s room temperature shelf life of slightly over 2 months and 5 times the competition’s normal cold-storage shelf life. Prior to this study, the standard for shelf life of TSA petri plates was for cold storage only, for a period of 3-1/2 months. In an additional milestone reached in internal Company cold storage tests, NanoLogix TSA petri plates are approaching three years on the shelf with no loss of viability from when first manufactured.
The importance of these results cannot be overstated --- due to their traditional short shelf lives, agar-filled petri plates have historically been prepared in locations in the states, regions, or countries in which the users are located. The long shelf life of NanoLogix products and the FlatPack’s virtual elimination of breakage in transit, regardless of distance shipped, are producing a paradigm shift on the part of those who are the product end users. Customers can now take delivery of NanoLogix products many thousands of miles distant from the production location and be assured that they have a product that significantly outlasts others made onsite, locally, or regionally. A number of our FlatPack protected petri-based products can be stored at room temperature for months or more, a feature that is unique to NanoLogix products and one that reduces energy requirements significantly on projects both large and small, with no need for cold storage equipment for our TSA: 19+ months (competition: 3-1/2 months), Nematode Growth Media (10+ months), and Chocolate Agar: 10+ months (competition 5 months). Our Middlebrook Agar petri plates for TB detection: 10+ months in cold storage, (competition: 3 months). We expect these times to be extended during the ongoing testing and hope that shelf life may be indefinite for some agars.
Results of the ongoing study should be submitted for publication sometime in 2014.
NanoLogix will be exhibiting at Booth 625 at the annual Food Safety Summit in Baltimore, Maryland April 8-10, 2014. Further information can be found at: http://www.foodsafetysummit.com/
About NanoLogix, Inc.
NanoLogix is a biotechnology company focused primarily on rapid diagnostics. Its products offer accelerated detection and identification of microorganisms. In addition to medical, National Defense, and homeland security applications, NanoLogix technology is applicable in pharmaceutical, industrial, veterinary and environmental testing.
Patents granted to NanoLogix can be used in the areas of applied microbiology, soil microbiology and bioremediation, microbial physiology, molecular biology, pharmacology, pharmaco-kinetics, and antibiotic sensitivity
For more information visit: http://nanologix.com/
This press release contains statements, which may constitute "forward- looking statements" within the meaning of the Securities Act of 1933 and the Securities Exchange Act of 1934, as amended by the Private Securities Litigation Reform Act of 1995. Those statements include statements regarding the intent, belief or current expectations of NanoLogix, Inc., and members of its management as well as the assumptions on which such statements are based. Prospective investors are cautioned that any such forward-looking statements are not guarantees of future performance and involve risks and uncertainties, and that actual results may differ materially from those contemplated by such forward-looking statements. The Company undertakes no obligation to update or revise forward-looking statements to reflect changed assumptions, the occurrence of unanticipated events or changes to future operating results.